Standalone iStent Infinite and iDose TR for Management of Moderate to Severe Open Angle Glaucoma
Standalone iStent Infinite and iDose TR for Management of Moderate to Severe Open Angle Glaucoma
Recruiting · NCT07228221 · Registry updated 2025-11-14Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Standalone iStent Infinite and iDose TR for Management of Moderate to Severe Open Angle Glaucoma | exfoliation glaucoma, exfoliation syndrome, eye disorder, glaucoma, iris disorder, ocular hypertension, open-angle glaucoma, uveal disorder | Recruiting | Phase 4 | 2025-11-14 | NCT07228221 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Glaukos Corporation | 13 |
| Jonathon Myers | 1 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Wills Eye Hosital Glaucoma Dept. | Philadelphia | United States | 1 |